HomeVideoIndian pharma groups buying U.S. assets

Indian pharma groups buying U.S. assets

Clashing business management styles between Indian and U.S. pharmaceutical firms is one of the major factors foreign venture capital firms should consider before investing in India’s burgeoning pharmaceutical sector, says Brandi Moore, founder of New York-based consulting firm India Think Consulting. In this video interview with The Deal Pipeline, Moore discusses the three major disease profiles affecting India’s growing population — diabetes, high blood pressure and heart disease — and how they could present big opportunities for VC firms looking to invest in India’s pharma market. Moore also chats about the most notable trend she sees in the sector today: Indian pharma groups buying up U.S. assets. – Sarah Hashim-Waris

Likes: 0



Previous post
దర్శకేంద్రుని హీరోయిన్ గోల్డ్ గౌన్ రేటెంతో తెలుసా! Pragya Jaiswal's 14 kg Gold Lehenga Cost? #ONV
Next post
WEGO video - Will Ryan

Leave a Reply

Be the First to Comment!

Notify of